SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
NYSE New York Stock Exchange
Börse NYSE New York Stock Exchange
ISIN US5324571083
USD
  • Eli Lilly and Co
    Börse NYSE New York Stock Exchange
    ISIN US5324571083
    Symbol LLY-WD
    USD
  • Eli Lilly
    Börse Börse Stuttgart
    ISIN XS1240751229
    Symbol LLY
    EUR
  • Eli Lilly and Company
    Börse Xetra Frankfurt
    ISIN US532457BV93
    Symbol LLY
    EUR
  • ELI LILLY & CO
    Börse Börse Berlin
    ISIN XS1240751062
    Symbol LLY
    EUR
  • ELI LILLY & CO
    Börse Börse Hamburg
    ISIN XS2075937370
    Symbol LLY
    EUR
  • ELI LILLY & CO
    Börse Gettex System der Börse München
    ISIN US532457BS64
    Symbol LLY
    EUR
  • ELI LILLY & CO
    Börse Quotrix System der Börse Düsseldorf
    ISIN XS1240750767
    Symbol LLY
    EUR
  • ELI LILLY & CO
    Börse Tradegate System der Deutsche Börse AG (60%)
    ISIN US532457BR81
    Symbol LLY
    EUR
  • ELI LILLY & CO
    Börse Börse Düsseldorf
    ISIN US532457AZ17
    Symbol LLY
    EUR
  • ELI LILLY & CO
    Börse Börse München
    Symbol LLY
    EUR
  • ELI LILLY & CO
    Börse Börse Frankfurt
    Symbol LLY
    EUR
  • ISIN US5324571083 WKN: 858560
    Symbol LLY
  • Eli Lilly and Company
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US532457BY33
  • Eli Lilly and Company
    Börse London Stock Exchange
    ISIN US532457BZ08
  • Eli Lilly and Company
    Börse BVMF
    ISIN US532457BQ09
  • Eli Lilly and Company
    Börse Bolsa de Comercio de Buenos Aires
    ISIN US532457BH00
ISIN US5324571083
Symbol LLY-WD
Währung USD
Börse NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Marktkapitalisierung 162.609.462.741 (+- 19%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

178.584.305.664 oder 193.976.000.000 oder 115.268.082.559

Mitarbeiter 35.897 (+- 9%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

35.065 oder 33.625 oder 39.000 Mitarbeiter

Anzahl Aktien 956.581.598
KGV 22.62 (+- 35%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

30.54 oder 14.7

EBITDA 7.741.799.936
PEGRatio 1.1871
Buchwert 5.325

Zahlte zuletzt am 13.05.2021 eine Dividende von 0,85 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht

Die Dividendenrendite entsprach 85,67 % p. a. beim aktuellen Kurs von 204,3 EUR +0,64% 

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 204,3 EUR +0,64% 

Aktionärsstruktur der Eli Lilly and Company

196 News & Informationen zur Eli Lilly Aktie

  • 10 Biotech Penny Stocks to Buy According to Reddit
    insidermonkey.com

    10 Biotech Penny Stocks to Buy According to Reddit

    In this article, we discuss the 10 biotech penny stocks to buy according to Reddit.

  • Eli Lilly (LLY) Reports Mix Q2 Financial Results
    insidermonkey.com

    Eli Lilly (LLY) Reports Mix Q2 Financial Results

    Eli Lilly and Co. (NYSE:LLY) was founded by a pharmacist named Colonel Eli Lilly way back in 1876.

  • Global Cancer Therapies Market to Reach $204.2 Billion by 2024
    prnewswire.com

    Global Cancer Therapies Market to Reach $204.2 Billion by 2024

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Global Osteoporosis Therapeutics Market to Reach $13.1 Billion by 2024
    prnewswire.com

    Global Osteoporosis Therapeutics Market to Reach $13.1 Billion by 2024

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Faze Medicines Appoints New Senior Vice President, Head Of People & Culture
    thestreet.com

    Faze Medicines Appoints New Senior Vice President, Head Of People & Culture

    BOSTON, Aug. 5, 2021 /PRNewswire/ — Faze Medicines, a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular

  • Rigel Pharmaceuticals : Reports Second Quarter 2021 Financial Results and Provides Business Update (Form 8-K)
    marketscreener.com

    Rigel Pharmaceuticals : Reports Second Quarter 2021 Financial Results and Provides Business Update (Form 8-K)

    Rigel Reports Second Quarter 2021 Financial Results and Provides Business Update

    Net product sales of $17.1 million and total… | August 3, 2021

  • S&P 500 Rides Energy, Health Care to Close at Record By Investing.com
    investing.com

    S&P 500 Rides Energy, Health Care to Close at Record By Investing.com

    S&P 500 Rides Energy, Health Care to Close at Record

  • Eli Lilly and Company (LLY) CEO David Ricks on Q2 2021 Results - Earnings Call Transcript
    seekingalpha.com

    Eli Lilly and Company (LLY) CEO David Ricks on Q2 2021 Results – Earnings Call Transcript

    Eli Lilly and Company (NYSE:LLY) Q2 2021 Results Conference Call August 3, 2021 9:00 AM ET Company Participants Kevin Hern – VP, IR David Ricks – Chairman, CEO & President Anat…

  • S&P 500 Climbs as Energy, Industrials Shine By Investing.com
    investing.com

  • Eli Lilly and Company 2021 Q2 - Results - Earnings Call Presentation (NYSE:LLY)
    seekingalpha.com

    Eli Lilly and Company 2021 Q2 – Results – Earnings Call Presentation (NYSE:LLY)

    The following slide deck was published by Eli Lilly and Company in conjunction with their 2021 Q2 earnings call.

  • 5 things to know before the stock market opens Tuesday
    cnbc.com

    5 things to know before the stock market opens Tuesday

    Dow futures gained more than 150 points Tuesday, a day after the 30-stock average gave up early gains and lost nearly 100 points.

  • Drugmaker Eli Lilly profit slips on weak demand for COVID-19 therapies By Reuters
    investing.com

    Drugmaker Eli Lilly profit slips on weak demand for COVID-19 therapies By Reuters

    Drugmaker Eli Lilly profit slips on weak demand for COVID-19 therapies

  • 5 Stocks To Watch For August 3, 2021
    benzinga.com

    5 Stocks To Watch For August 3, 2021

    Some of the stocks that may grab investor focus today are: Wall Street expects Alibaba Group Holding Ltd – ADR (NYSE: BABA) to report quarterly earnings at …

  • First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
    financialpost.com

    First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development

    Breakthrough results in the treatment of a type of heart failure, which is extremely difficult to manage Strong progress in mental health pipeline Good…

  • US stocks edge down on virus woes, slowing economy
    news.abs-cbn.com

    US stocks edge down on virus woes, slowing economy

    The S&P 500 Index closed slightly lower on Monday after erasing early gains as worries about the Delta variant of the coronavirus and a slowing US economy overshadowed optimism around more fiscal stimulus and a strong second-quarter earnings season.

  • CytRx : Announces Director Election Results from 2021 Annual Meeting of Stockholders (Form 8-K)
    marketscreener.com

    CytRx : Announces Director Election Results from 2021 Annual Meeting of Stockholders (Form 8-K)

    CytRx Announces Director Election Results from 2021 Annual Meeting of Stockholders

    New Director Dr. Jennifer K. Simpson Added to CytRx Board of Directors

    July… | July 30, 2021

  • 15 Most Valuable Biotech Companies in the World
    insidermonkey.com

    15 Most Valuable Biotech Companies in the World

    In this article we will take a look at the 15 most valuable biotech companies in the world. You can skip our detailed analysis of the biotechnology industry…

  • Eli Lilly and : Lilly releases donanemab data that demonstrated relationship between reduction of amyloid plaque and slowing of cognitive...
    marketscreener.com

    Eli Lilly and : Lilly releases donanemab data that demonstrated relationship between reduction of amyloid plaque and slowing of cognitive decline

    INDIANAPOLIS, July 29, 2021 /PRNewswire/ — Today at the Alzheimer's Association International Conference© , Eli Lilly and Company presented two new exploratory analyses of data from the… | July 29, 2021

  • Lilly releases donanemab data that demonstrated relationship between reduction of amyloid plaque and slowing of cognitive decline
    prnewswire.com

    Lilly releases donanemab data that demonstrated relationship between reduction of amyloid plaque and slowing of cognitive decline

    /PRNewswire/ — Today at the Alzheimer's Association International Conference© (AAIC© 2021), Eli Lilly and Company (NYSE: LLY) presented two new exploratory…

  • Crohn's Disease Market Set to Observe Remunerative Growth at a CAGR of 7.6% During the Study Period 2018-30
    prnewswire.com

    Crohn's Disease Market Set to Observe Remunerative Growth at a CAGR of 7.6% During the Study Period 2018-30

    /PRNewswire/ — DelveInsight's Crohn's Disease (CD) Market report offers comprehensive coverage of the current treatment practices, pipeline drugs, Crohn's…

  • FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring oxygen
    prnewswire.com

    FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring oxygen

    /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today the U.S. Food and Drug Administration (FDA) has broadened the…

  • FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring oxygen
    markets.businessinsider.com

    FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring oxygen

    INDIANAPOLIS, July 29, 2021 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today the U.S. Food and Drug Admi…

  • Rubius Therapeutics Appoints Dannielle Appelhans As Chief Operating Officer
    thestreet.com

    Rubius Therapeutics Appoints Dannielle Appelhans As Chief Operating Officer

    CAMBRIDGE Mass., July 29, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically

  • Dicerna Announces FDA Clearance Of Investigational New Drug (IND) Application For DCR-AUD For The Treatment Of Alcohol Use Disorder
    thestreet.com

    Dicerna Announces FDA Clearance Of Investigational New Drug (IND) Application For DCR-AUD For The Treatment Of Alcohol Use Disorder

    Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (“Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)

  • Domino’s, Eli Lilly, McDonald’s, Merck and More Tuesday Afternoon Analyst Upgrades and Downgrades – 24
    247wallst.com

    Domino’s, Eli Lilly, McDonald’s, Merck and More Tuesday Afternoon Analyst Upgrades and Downgrades – 24

    24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Tuesday, including Domino’s, Eli Lilly, Harley-Davidson, McDonald’s and Merck.

  • Global Polycythemia Vera Therapeutics Market to Surpass US$ 1,516.5 Million by 2028, Says Coherent Market Insights (CMI)
    globenewswire.com

    Global Polycythemia Vera Therapeutics Market to Surpass US$ 1,516.5 Million by 2028, Says Coherent Market Insights (CMI)

    SEATTLE, July 27, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global polycythemia vera therapeutics market is estimated to be…

  • Rigel Announces Conference Call And Webcast To Report Second Quarter 2021 Financial Results And Business Update
    thestreet.com

    Rigel Announces Conference Call And Webcast To Report Second Quarter 2021 Financial Results And Business Update

    SOUTH SAN FRANCISCO, Calif., July 27, 2021 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its second quarter

  • 3 Biotech Stocks That Could Rocket Higher
    fool.com

    3 Biotech Stocks That Could Rocket Higher

    Over the past year, these small-cap drugmakers have done well by their shareholders, and more big catalysts could be coming.

  • Worldwide Rapid Acting Insulin Industry to 2027 - Players Include Merck & Co, Sanofi and Novo Nordisk Among Others
    prnewswire.com

    Worldwide Rapid Acting Insulin Industry to 2027 – Players Include Merck & Co, Sanofi and Novo Nordisk Among Others

    /PRNewswire/ — The “Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report…

  • Worldwide Rapid Acting Insulin Industry To 2027 - Players Include Merck & Co, Sanofi And Novo Nordisk Among Others
    thestreet.com

    Worldwide Rapid Acting Insulin Industry To 2027 – Players Include Merck & Co, Sanofi And Novo Nordisk Among Others

    DUBLIN, July 22, 2021 /PRNewswire/ — The “Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook,

  • Hedge Funds Never Been Less Bullish On Novartis AG (NVS)
    insidermonkey.com

    Hedge Funds Never Been Less Bullish On Novartis AG (NVS)

    The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their…

  • Lilly Confirms Date and Conference Call for Second-Quarter 2021 Financial Results Announcement
    prnewswire.com

    Lilly Confirms Date and Conference Call for Second-Quarter 2021 Financial Results Announcement

    /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2021 financial results on Tuesday, August 3, 2021. Lilly will also conduct a…

  • Glenmark Life Sciences IPO opens on July 27: 10 things to know before the issue
    moneycontrol.com

    Glenmark Life Sciences IPO opens on July 27: 10 things to know before the issue

    Glenmark Life Sciences IPO: The company plans to raise Rs 1,497.85 crore at the lower end and Rs 1,513.6 crore at the higher end of the price band.

  • Global Telemedicine Market Market Report 2021-21026 with Analysis of CEVA, Inc, Eli Lilly and Co, Bayer AG, Merck & Co, Teladoc Health, Inc.
    prnewswire.com

    Global Telemedicine Market Market Report 2021-21026 with Analysis of CEVA, Inc, Eli Lilly and Co, Bayer AG, Merck & Co, Teladoc Health, Inc.

    /PRNewswire/ — The “Telemedicine Market, Global Forecast Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview, Financial Insight” report…

  • Global Telemedicine Market Market Report 2021-21026 With Analysis Of CEVA, Inc, Eli Lilly And Co, Bayer AG, Merck & Co, Teladoc Health, Inc.
    thestreet.com

    Global Telemedicine Market Market Report 2021-21026 With Analysis Of CEVA, Inc, Eli Lilly And Co, Bayer AG, Merck & Co, Teladoc Health, Inc.

    DUBLIN, July 21, 2021 /PRNewswire/ — The “Telemedicine Market, Global Forecast Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview,

  • Dicerna Announces Interim Results From Phase 1 Trial Of Belcesiran For Treatment Of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
    thestreet.com

    Dicerna Announces Interim Results From Phase 1 Trial Of Belcesiran For Treatment Of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

    Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Eli Lilly Aktie

Das Unternehmen Eli Lilly and Company aus USA beschäftigt 35.897 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Einzelhandel (Medikamente), Einzelhandel, Pharma tätig.

Das Unternehmen Eli Lilly and Company ist in mehr als 72 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Pharmaceutical ETF gewichtet Eli Lilly mit 5,66% im ETF.

Entdecke die 6 ETFs in denen Eli Lilly and Company am höchsten gewichtet ist Insgesamt in 72 ETFs enthalten

Dir gefallen die Informationen zu Eli Lilly?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Eli Lilly?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Eli Lilly?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Eli Lilly?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero